Evidence map›Paper›PMID 24766985›Full record

Observational studyAmerican heart journal2014

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Benjamin A Steinberg, Sunghee Kim, Gregg C Fonarow, Laine Thomas, Jack Ansell, Peter R Kowey, Kenneth W Mahaffey, Bernard J Gersh, Elaine Hylek, Gerald Naccarelli and 5 more

Open access · greenAbstract readComparative StudyMulticenter StudyObservational Study
In one paragraph

Observational study in American heart journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2016
    Trial
  5. Trial
  6. Article
  7. Symptom severity assessment in patients with atrial fibrillation after catheter ablation using a smartphone application.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  8. Article
  9. Observational
  10. The impact of heat and cold events on direct, indirect, and intangible healthcare costs: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  11. Critique on the Fibrillatory Wave Amplitude of ECG Decreases Over Time in Patients With Persistent AF.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2026
    Article
  12. Quality of life before and after catheter ablation (pulmonary vein isolation) for atrial fibrillation: Results from the Netherlands Heart Registration.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2026
    Article
  13. Article
  14. Review
  15. Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  16. Article
  17. Observational
  18. Review
  19. Article
  20. Assessing the impact of atrial fibrillation self-care interventions: A systematic review.American heart journal plus : cardiology research and practice · 2024
    Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 2 countries.

Benjamin A SteinbergDuke University Medical Center, Durham, NC; Duke Clinical Research Institute, Durham, NC. Electronic address: benjamin.steinberg@duke.edu.
Sunghee KimDuke Clinical Research Institute, Durham, NC.
Gregg C FonarowUCLA Division of Cardiology, Los Angeles, CA. Electronic address: GFonarow@mednet.ucla.edu.
Laine ThomasDuke Clinical Research Institute, Durham, NC.
Jack AnsellNew York University School of Medicine, Lenox Hill Hospital, New York, NY. Electronic address: ansellje@gmail.com.
Peter R KoweyLankenau Institute for Medical Research, Wynnewood, PA. Electronic address: KoweyP@mlhs.org.
Kenneth W MahaffeyStanford University School of Medicine, Stanford, CA. Electronic address: Kenneth.mahaffey@stanford.edu.
Bernard J GershMayo Clinic, Rochester, MN. Electronic address: gersh.bernard@mayo.edu.
Elaine HylekBoston University School of Medicine, Boston, MA. Electronic address: Elaine.Hylek@bmc.org.
Gerald NaccarelliPenn State University School of Medicine, Hershey, PA. Electronic address: gnaccarelli@hmc.psu.edu.
Alan S GoKaiser Permanente, Oakland, CA. Electronic address: alan.s.go@kp.org.
James ReiffelColumbia University College of Physicians and Surgeons, New York, NY. Electronic address: jar2@columbia.edu.
Paul ChangJanssen Pharmaceuticals, Inc., Raritan, NJ. Electronic address: PChang9@its.jnj.com.
Eric D PetersonDuke University Medical Center, Durham, NC; Duke Clinical Research Institute, Durham, NC.
Jonathan P PicciniDuke University Medical Center, Durham, NC; Duke Clinical Research Institute, Durham, NC.
Duke Medical Center · USBoston University · USClinical Research Institute · USDurham University · GBJanssen (United States) · USKaiser Permanente · USLankenau Institute for Medical Research · USLenox Hill Hospital · USMayo Clinic · USPenn State Milton S. Hershey Medical Center · USUCLA Health · US

Funding

MULTIDISCIPLINARY HEART &VASCULAR DISEASEST32HL007101 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 1985 to 2020
$9.8M
NHLBI NIH HHS 5 T32 HL 7101-38NHLBI NIH HHS T32 HL007101
6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) is the most common cardiac dysrhythmia and contributes significantly to health care expenditures. We sought to assess the frequency and predictors of hospitalization in patients with AF.

methodsThe ORBIT-AF registry is a prospective, observational study of outpatients with AF enrolled from June 29, 2010, to August 9, 2011. The current analysis included 9,484 participants with 1-year follow-up. Multivariable, logistic regression was used to identify baseline characteristics that were associated with first cause-specific hospitalization.

resultsOverall, 31% of patients with AF studied (n = 2,963) had 1 or more hospitalizations per year and 10% (n = 983) had 2 or more. The most common hospitalization cause was cardiovascular (20 per 100 patient-years vs 3.3 bleeding vs 17 noncardiovascular, nonbleeding). Compared with those not hospitalized, hospitalized patients were more likely to have concomitant heart failure (42% vs 28%, P < .0001), higher mean CHADS2 (1 point for congestive heart failure, hypertension, age ≥75, or diabetes; 2 points for prior stroke or transient ischemic attack) scores (2.5 vs 2.2, P < .0001), and more symptoms (baseline European Heart Rhythm Association class severe symptoms 18% vs 13%, P < .0001). In multivariable analysis, heart failure (adjusted hazard ratio [HR] 1.57 for New York Heart Association III/IV vs none, P < .0001), heart rate at baseline (adjusted HR 1.11 per 10-beats/min increase >66, P < .0001), and AF symptom class (adjusted HR 1.37 for European Heart Rhythm Association severe vs none, P < .0001) were the major predictors of incident hospitalization.

conclusionsHospitalization is common in outpatients with AF and is independently predicted by heart failure and AF symptoms. Improved symptom control, rate control, and comorbid condition management should be evaluated as strategies to reduce health care use in these patients.

Indexed as

RegistriesAgedAtrial FibrillationDisease ProgressionFemaleFollow-Up StudiesHeart FailureHospitalizationHumansIncidenceMalePrognosisProspective StudiesRisk AssessmentRisk FactorsTime Factors

Identifiers

PMID24766985
PMCPMC4006943
OpenAlexW2032270950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.